XTAI2905
Market cap508mUSD
Dec 25, Last price
15.60TWD
1D
-0.95%
1Q
-16.13%
Jan 2017
-21.09%
Name
Mercuries & Associates Holding Ltd
Chart & Performance
Profile
Mercuries & Associates Holding, Ltd., an investment holding company, engages in life insurance, daily commodities and food retail, pharmaceuticals, and information services businesses. The company offers lifetime and whole life insurance; hospitalization and medical care, cancer, and whole life medical and healthcare insurance; personal accident, travel, and online accident insurance; immediate and deferred annuity insurance, and pension insurance with floating interest rates; variable annuity and variable life insurance; 1-year term group life and group health insurance; group accident insurance; and long-term care lifetime, and disability care lifetime health insurance, as well as pension in foreign currencies. It also purchases and sells daily commodities and food, alcohols, beverages, tobacco, daily necessities, cooked food, fresh foods, medical supplies, infant products, cosmetics, and beauty products; and branded footwear, apparel, and accessories, as well as serves fast food, including noodles, rice, fried pork chops, Japanese bento sets, and pizzas. In addition, the company engages in the sale and decoration of furniture, cabinets, kitchen utensils, and mattresses. Further, it manufactures active pharmaceutical ingredients (API), such as valporic acid and allopurinol; API intermediates comprising diethyl dipropyl malonate and PENT-2 ethyl 2-allyl-2-cyano-3-methylhexanoate; and specialty chemicals that include diethyl ketone. Additionally, the company offers software and hardware planning, development, and establishment services for financial information systems and public utilities; and software and hardware maintenance services. The company was formerly known as Mercuries & Associates, Ltd. and changed its name to Mercuries & Associates Holding, Ltd. in January 2015. The company was founded in 1965 and is headquartered in Taipei, Taiwan.
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 159,999,775 8.45% | 147,538,411 -11.22% | 166,189,852 -21.11% | |||||||
Cost of revenue | 165,236,846 | 153,018,939 | 171,865,823 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (5,237,071) | (5,480,528) | (5,675,971) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | (3,227,491) | (1,142,229) | (1,965,773) | |||||||
Tax Rate | ||||||||||
NOPAT | (2,009,580) | (4,338,299) | (3,710,198) | |||||||
Net income | (2,874,182) -77.17% | (12,591,066) -582.05% | 2,611,988 3.55% | |||||||
Dividends | (108,841) | (977,635) | (1,025,406) | |||||||
Dividend yield | 0.86% | 7.29% | 4.61% | |||||||
Proceeds from repurchase of equity | 7,533,158 | 5,673,751 | 1,295,886 | |||||||
BB yield | -59.20% | -42.31% | -5.83% | |||||||
Debt | ||||||||||
Debt current | 5,203,304 | 3,400,153 | 2,854,338 | |||||||
Long-term debt | 23,214,355 | 26,622,993 | 23,185,135 | |||||||
Deferred revenue | 1,043,287 | 8,196 | 10,644 | |||||||
Other long-term liabilities | 1,456,457,963 | 1,409,682,864 | 1,343,537,646 | |||||||
Net debt | (88,317,790) | (1,150,788,920) | (1,107,848,820) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (37,934,929) | (64,409,953) | 66,479,018 | |||||||
CAPEX | (1,856,393) | (3,053,291) | (5,097,014) | |||||||
Cash from investing activities | 46,371,745 | 6,855,542 | (112,574,623) | |||||||
Cash from financing activities | 8,295,102 | 7,438,958 | (1,779,733) | |||||||
FCF | (171,068) | (3,411,626) | (11,052,066) | |||||||
Balance | ||||||||||
Cash | 64,874,495 | 50,375,964 | 100,756,675 | |||||||
Long term investments | 51,860,954 | 1,130,436,102 | 1,033,131,618 | |||||||
Excess cash | 108,735,460 | 1,173,435,145 | 1,125,578,800 | |||||||
Stockholders' equity | 36,971,887 | 36,914,757 | 45,798,232 | |||||||
Invested Capital | 1,491,027,404 | 1,430,093,628 | 1,366,809,962 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 928,826 | 885,249 | 991,447 | |||||||
Price | 13.70 -9.57% | 15.15 -32.44% | 22.43 9.42% | |||||||
Market cap | 12,724,916 -5.12% | 13,411,516 -39.68% | 22,233,935 23.56% | |||||||
EV | (44,180,210) | (1,115,883,871) | (1,058,109,930) | |||||||
EBITDA | (2,681,868) | (3,000,127) | (3,203,199) | |||||||
EV/EBITDA | 16.47 | 371.95 | 330.33 | |||||||
Interest | 251,546 | 149,100 | 110,320 | |||||||
Interest/NOPBT |